 |
 |
|
|
|
|
|
|
|
|
|
|
|
This
Summit gives you the platform to forecast your path
of excellence and understand key dynamics and drivers
in 2008 that will reshape the characteristics of the
global market.
Speakers
Confirmed to date:
- Bjarne
Lemmich, Global Head of Sales Forecasting
, Novartis
- Gavin
Heaney , Director International
Commercial Operations , Gilead
- Martin
Joseph, Head of Forecasting & Information
Management, AstraZeneca
- Nic
Talbot-Watt, Director of Forecasting,
GE Healthcare
- Alex
Baralt , Demand Manager, Abbott
- Manuel
Reiberg, Senior Manager Market Research
, Daiichi Sankyo
- Peter
Lena , Director of Forecasting, Sepracor
- Thierry
Boutin, Head of Forecasting Market Analytics,
Sanofi-Aventis
- Binyah
Kesselly, Director of Excellence in Commercialization,
Johnson & Johnson
- Susan
Ward, CEO , Global Demographics
Healthcare
- Gary
Johnson , Managing Director, Inpharmation
- Etienne
Adriansen, Director of Strategic Business
Planning, Nycomed
- Eric
Rambeaux, VP - Business Strategy &
Portfolio, Solvay
- Art
Cook, Principal, ZS Associates
- Rafaat
Rahmani, CEO , Lifescience
Dynamics
- Graham Clarke, CEO,
Immunobiology
- Stefano Malvolti,
Global Head of Forecasting, Novartis
- Richard Murgatroyd,
Global Forecasting Manager,
Roche
- Paul Goodwin ,
Professor of Management Science , University
of Bath
- Lars Nordmann, Director
of Forecasting, Organon
Eyeforpharma
Forecasting summit will bring together a top selection
of Pharma specialists and experienced professionals
to share their knowledge, to share their views and
present on the hottest topics around forecasting.
|
FORECAST EMERGING
MARKETS (COUNTRIES) AND / OR THERAPY AREAS:
Understand needs across multiple functional
areas, and the diversity of geography. |
|
SELECT
APPROPRIATE TOOLS FOR NEW PRODUCT AND IN-MARKET
FORECASTS: Drive resource allocation
decisions. What products are the most responsive
to sales and marketing efforts? |
|
SELECT
THE APPROPRIATE ANALOGUE(S) IN FORECASTING NEW
PRODUCTS: Understand options valuation
techniques – long used in assessing the
equities markets |
|
USE
MARKET RESEARCH AND PRICING ANALYSES:
Changes in the market environment (health care
policy) or a change in price needs to be quantified
by the forecaster |
|
INCORORATE
RISK AND UNCERTAINTY IN FORECASTING:
Model the responsiveness of product potential
to changes in the R&D resource allocation |
|
ALIGN
HQ AND AFFILIATE NEW PRODUCT FORECASTS AND MANAGE
THE "POLITICS OF FORECASTING": Address
these issues head-on and present best practices
in meeting these challenges.
|
|
TIME HORIZONS
IN FORECASTING: Create a transition,
while maintaining a reasonable growth trajectory
throughout a year |
|
FORECAST THE
EFFECTS OF VARYING RESOURCE LEVELS BEHIND A
PRODUCT: Focus on what each partner
contributes to overall product success, and
what incremental gains might be made through
co-promotion opportunities |
|
FORECAST WHOLESALER
INVENTORY IN ADDITION TO PATIENT DEMAND:
Evaluate different policy options, or a forecast
that explicitly evaluates the contributions
of two companies to a product’s revenue
potential |
Click
here to download the latest brochure
The
above topics will be covered at our unique conference:
Please send
your ideas, suggestions, proposals to Richard Bracchi
on richard@eyeforpharma.com
(or +44 207 375 7203)
|
|
|
|
